At a glance
ClinicalIndex Comparison RecordN/ACompleted· 123 enrolled
Drug / intervention
Azithromycin SR +1 moredrug
Likely dose
Amoxiclav 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
In Brief
An observational study evaluating Azithromycin SR and Amoxiclav 1000 mg for Maxillary Sinusitis. Completed, enrolled 123 participants.
Detailed Summary
The purpose of this study is to compare compliance between patients with Acute Bacterial Sinusitis (ABS) treated with Azithromycin SR 2.0 g single dose orally and those treated with Amoxiclav - 1000 mg twice daily 10 days for the empiric treatment of ABS in outpatient clinic practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMaxillary Sinusitis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 2009
Enrollment StartApr 2010
Primary CompletionMar 2011
TodayJul 2026
First PostedDec 15, 2009
Enrollment StartApr 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.5 years ago
Interventions
Azithromycin SRdrug
Azithromycin SR, 2.0 g by mouth (PO) x 1
Amoxiclav 1000 mgdrug
Amoxiclav 1000 mg x twice daily, 10 days